The relationship between in vitro drug dissolution and in vivo absorption

Journal of the Royal Statistical Society Series D: The Statistician

Volumn 48, Issue 1, 1999, Pages 125-133

  Dunne, Adrian ^b   Devane, John ^a   O'Hara, Thomas ^a  

^a ELAN PHARMACEUTICALS   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hotelling's T2 test; In vitro drug dissolution; In vivo drug absorption; Mixed effects models

Indexed keywords

EID: 0039697009     PISSN: 00390526     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-9884.00176     Document Type: Article

References (22)

1. Banakar U. V. (1992) Pharmaceutical Dissolution Testing. New York: Dekker.
2. Crowder M. J. (1996) Keep timing the tablets: statistical analysis of pill dissolution rates. Appl. Statist., 45, 323-334.
3. Crowder M. J. and Hand, D. J. (1990) Analysis of Repeated Measures. London: Chapman and Hall.
4. Dietrich, R., Brausse, R., Benedikt, G. and Steinijans, V. W. (1988) Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation. Arzneim. Forsch. Drug Res., 38, 1229-1237.
5. Diggle, P. J., Liang, K. Y. and Zeger, S. L. (1994) Analysis of Longitudinal Data. Oxford: Oxford University Press.
6. Food and Drug Administration (1997) Guidance for Industry, Extended Release Oral Dosage Forms; Development, Evaluation and Application of In Vitro/In Vivo Correlations. Rockville: Food and Drug Administration.
7. Gibaldi, M. and Perrier, D. (1982) Pharmacokinetics. New York: Dekker.
8. Humbert, H., Cabiac, M. D. and Bosshardt, H. (1994) In vitro-in vivo correlation of a modified-release oral form of ketotifen: in vitro dissolution rate specification. J. Pharm. Sci., 83, 131-136.
9. Hussein, Z. and Friedman, M. (1990) Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation. Pharm. Res., 7, 1167-1171.
10. Hwang, S. S., Gorsline, J., Louie, J., Dye, D., Guinta, D. and Hamel, L. (1995) In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product. J. Clin. Pharmacol., 35, 259-267.
11. Leeson, L. J. (1995) In vitro/in vivo correlations. Drug Inform. J., 29, 903-915.
12. Levy, G. and Hollister, L. E. (1965) Dissolution rate limited absorption in man. J. Pharm. Sci., 54, 1121-1125.
13. Makoid, M. C., Dufour, A. and Banakar, U. V. (1993) Modelling of dissolution behaviour of controlled release systems. S. T. P. Pharm. Prat., 3, 237-246.
14. Mojaverian, P., Radwanski, E., Lin, C. C., Cho, P., Vadino, W. A. and Rosen, J. M. (1992) Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations. Pharm. Res., 9, 450-456.
15. Morrison, D. F. (1978) Multivariate Statistical Methods. Singapore: McGraw-Hill.
16. Polli, J. E., Crison, J. R. and Amidon, G. L. (1996) Novel approach to the analysis of in vitro-in vivo relationships. J. Pharm. Sci., 85, 753-759.
17. Skelly, J. P., Amidon, G. L., Barr, W. H., Benet, L. Z., Carter, J. E., Robinson, J. R., Shah, V. P. and Yacobi, A. (1990) In vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms. Pharm. Res., 7, 975-982.
18. Skelly, J. P., Barr, W. H., Benet, L. Z., Daluisio, J. T., Goldberg, A. H., Levy, G., Lowenthal, D. T., Robinson, J. R., Shah, V. P., Temple, R. J. and Yacobi, A. (1987) Report of the workshop on controlled-release dosage forms: issues and controversies. Pharm. Res., 4, 75-77.
19. Skelly, J. P. and Shiu, G. F. (1993) In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications. Eur. J. Drug Metab. Pharmacokinet., 18, 121-129.
20. Snedecor, G. W. and Cochran, W. G. (1989) Statistical Methods. Ames: Iowa State University Press.
21. United States Pharmacopia (1988) In-vitro/in vivo correlation for extended-release oral dosage forms. Pharmacop. Forum, 14, 4160-4161.
22. _(1993) In vitro and in vivo evaluation of dosage forms. Pharmacop. Forum, 19, 5366-5379.